Itzhh SB 130mg Capsule contains Itraconazole 130mg, an antifungal agent belonging to the triazole class, indicated for the treatment of various systemic and superficial fungal infections. Itraconazole exerts its therapeutic effect by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. This medication is commonly prescribed for conditions such as aspergillosis, histoplasmosis, blastomycosis, onychomycosis, and other dermatophytic infections. Itzhh SB 130mg Capsule is administered orally and should be taken with food to enhance absorption. The dosage and duration of therapy depend on the type and severity of the infection, as well as patient-specific factors. Caution is advised in patients with hepatic impairment or congestive heart failure, as itraconazole may exacerbate these conditions. Common adverse effects include gastrointestinal disturbances, headache, dizziness, and rash. Itzhh SB 130mg Capsule may interact with several medications metabolized by the cytochrome P450 system, necessitating careful review of concomitant therapies. Regular monitoring of liver function tests is recommended during prolonged treatment. This product should be used under medical supervision to ensure safety and efficacy.